Prophylactic Pegfilgrastim to Prevent Febrile Neutropenia Among Patients Receiving Biweekly (Q2W) Chemotherapy Regimens: a Systematic Review of Efficacy, Effectiveness and Safety

Reshma Mahtani; Jeffrey Crawford; Sinéad M. Flannery; Tatiana Lawrence; Jennifer Schenfeld; Prasad L. Gawade

Prophylactic Pegfilgrastim to Prevent Febrile Neutropenia Among Patients Receiving Biweekly (Q2W) Chemotherapy Regimens: a Systematic Review of Efficacy, Effectiveness and Safety

Reshma Mahtani, Jeffrey Crawford, Sinéad M. Flannery, Tatiana Lawrence, Jennifer Schenfeld, Prasad L. Gawade

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	BMC Cancer
Volume	21
State	Published - 2021

Disciplines

Medicine and Health Sciences

Cite this

@article{981f645f0aac477c82fb38adb1e829ef,

title = "Prophylactic Pegfilgrastim to Prevent Febrile Neutropenia Among Patients Receiving Biweekly (Q2W) Chemotherapy Regimens: a Systematic Review of Efficacy, Effectiveness and Safety",

author = "Reshma Mahtani and Jeffrey Crawford and Flannery, \{Sin{\'e}ad M.\} and Tatiana Lawrence and Jennifer Schenfeld and Gawade, \{Prasad L.\}",

note = "doi: 10.1186/s12885-021-08258-w. 1 Sylvester Cancer Center, University of Miami, Deerfield Beach, FL, USA. [email protected]. 2 Duke Cancer Institute, Durham, NC, USA. 3 Oxford PharmaGenesis Ltd, London, UK. 4 US Medical, Amgen, Thousand Oaks, CA, USA. 5 Center for Observational Research, Amgen, Thousand Oaks, CA, USA. Free PMC article Reshma Mahtani et al.",

year = "2021",

language = "American English",

volume = "21",

journal = "BMC Cancer",

}

TY - JOUR

T1 - Prophylactic Pegfilgrastim to Prevent Febrile Neutropenia Among Patients Receiving Biweekly (Q2W) Chemotherapy Regimens: a Systematic Review of Efficacy, Effectiveness and Safety

AU - Mahtani, Reshma

AU - Crawford, Jeffrey

AU - Flannery, Sinéad M.

AU - Lawrence, Tatiana

AU - Schenfeld, Jennifer

AU - Gawade, Prasad L.

N1 - doi: 10.1186/s12885-021-08258-w. 1 Sylvester Cancer Center, University of Miami, Deerfield Beach, FL, USA. [email protected]. 2 Duke Cancer Institute, Durham, NC, USA. 3 Oxford PharmaGenesis Ltd, London, UK. 4 US Medical, Amgen, Thousand Oaks, CA, USA. 5 Center for Observational Research, Amgen, Thousand Oaks, CA, USA. Free PMC article Reshma Mahtani et al.

PY - 2021

Y1 - 2021

UR - https://pubmed.ncbi.nlm.nih.gov/34044798/

M3 - Article

VL - 21

JO - BMC Cancer

JF - BMC Cancer

ER -

Prophylactic Pegfilgrastim to Prevent Febrile Neutropenia Among Patients Receiving Biweekly (Q2W) Chemotherapy Regimens: a Systematic Review of Efficacy, Effectiveness and Safety

Disciplines

Other files and links

Cite this